A South Australian company has launched a portable isolation hospital for widespread medical emergency hotspots to treat patients with respiratory illnesses during the pandemic.
Based in Adelaide, Humanihut’s isolation hospital has received expressions of interest from government clients in Australia, the US, Europe and Middle East to better prepare for future epidemics or health crises.
The deployable medical facility was adapted in partnership with French-based business Utilis International from Humanihut designs for disaster accommodation. Humanihut co-founder and Managing Director Neale Sutton said the new model was created for the COVID-19 outbreak in New York and serves as an efficient market-ready alternative to tents, which are the current industry standard for field hospitals.
“In the initial stages, the [coronavirus] epidemic had governments around the globe looking for very quick solutions to assist the pressure that was being placed on their medical facilities,” Sutton said.
“We’re now focusing our product into the longer term, it’s about what comes next after Covid-19 and after all of the equipment has been used on this outbreak; is there enough to be used for the next outbreak?” He said the ‘Florey’ portable isolation model costs A$200,000 per bed in comparison to approximately $1.5 million per bed for a hospital.”
In its basic configuration, the isolation hospital comprises of 16 flatpack huts each measuring 6m x 2.3m (19f x 7.5f), set up as single-bed patient rooms attached with en-suites, which stand between two 40ft containers housing a nurse’s station, staffroom, kitchen, bathroom and laundry.
“The Humanihut Florey system is a far more robust and rapidly deployable system than just about anything else that’s around,” he added. “We’re talking to a number of prospective clients around the world about the part we can play in their operations going forward looking over their horizon to 2021 and beyond.” Sutton said he was in talks with a local government in the US for the purchase of a Florey unit within the next 12 months.